Portage Biotech Newsroom

Portage Biotech Analyst Ratings

BenzingaJan 9 02:36

Analysts Offer Insights on Healthcare Companies: Harpoon Therapeutics (HARP), Portage Biotech Inc (PRTG) and Ambrx Biopharma (AMAM)

TipRanksJan 9 02:00

HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $6

BenzingaNov 30, 2023 04:01

Portage Biotech Analyst Ratings

BenzingaNov 30, 2023 04:00

Portage Biotech Inc: A Buy Rating Amid Future Catalysts and Strategic Acquisitions

TipRanksNov 30, 2023 00:35

Cantor Fitzgerald Reiterates Overweight on Portage Biotech, Maintains $11 Price Target

BenzingaSep 7, 2023 23:38

Portage Biotech Analyst Ratings

BenzingaSep 7, 2023 23:37

Cantor Fitzgerald Reiterates Overweight on Portage Biotech, Maintains $11 Price Target

BenzingaAug 31, 2023 21:23

Portage Biotech Analyst Ratings

BenzingaAug 31, 2023 21:22

Portage Biotech Inc (PRTG) Receives a Buy From H.C. Wainwright

TipRanksAug 2, 2023 18:25

HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $9

BenzingaAug 2, 2023 18:23

Portage Biotech Analyst Ratings

BenzingaAug 2, 2023 18:23

Cantor Fitzgerald Maintains Overweight on Portage Biotech, Lowers Price Target to $11

BenzingaAug 1, 2023 21:26

Portage Biotech Analyst Ratings

BenzingaAug 1, 2023 21:25

HC Wainwright Adjusts Portage Biotech's Price Target to $21 From $22, Keeps Buy Rating

MT NewswiresDec 1, 2022 23:22

Portage Biotech Analyst Ratings

Benzinga Analyst RatingsDec 1, 2022 19:16

HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $21

Benzinga Real-time NewsDec 1, 2022 19:15

Oppenheimer Adjusts Portage Biotech Price Target to $18 From $26, Maintains Outperform Rating

MT NewswiresNov 30, 2022 21:56

Portage Biotech Analyst Ratings

Benzinga Analyst RatingsNov 30, 2022 20:21

Oppenheimer: maintain the Portage Biotech (PRTG.US) better than the market rating, with the target price adjusted to $18.00 from $26.00.

Zhitong FinanceNov 30, 2022 20:00